Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. chil. reumatol ; 22(4): 155-160, 2006. tab
Article in Spanish | LILACS | ID: lil-471362

ABSTRACT

Nervous system involvement in Sjõgren's syndrome (SS) is extensive in its clinical expression and can be extremely serious, nevertheless it has been poorly studied. It can involve both the peripheral nervous system and the central nervous system, while immunological and vascular mechanism have been related to its genesis. The disease is subclinical in a good number of patients and should be looked for directly. In others however, it is the first symptom.


Subject(s)
Humans , Nervous System Diseases/etiology , Sjogren's Syndrome/complications , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/immunology , Autonomic Nervous System/physiopathology , Central Nervous System/physiopathology , Peripheral Nervous System/physiopathology
2.
Rev. Hosp. Clin. Univ. Chile ; 16(3): 198-203, 2005. tab, ilus
Article in Spanish | LILACS | ID: lil-531909

ABSTRACT

Revisamos los hallazgos clínicos, patológicos y tratamiento en 12 pacientes con mucormicosis en el Hospital Clínico de la Universidad de Chile entre los años 1990 y 2004. Del total de pacientes estudiados, 7 eran hombres y 5 mujeres. La edad promedio fue de 54 años, con un rango de 29 a 79 años. El diagnóstico de mucormicosisse realizó por biopsia en 10 pacientes y por estudio directo en 2 pacientes. Los factores predisponentes presentes en los pacientes estudiados fueron, diabetes mellitus, HIV en etapa SIDA y enfermedades hematológicas en tratamiento oncológico. La histología demostró necrosis e infarto con invasión de vasos sanguíneos y trombosis micótica. Todos los pacientes estudiados recibieron tratamiento con Anfotericina B y 6 fueron intervenidos quirúrgicamente. Del total de 12 pacientes, 4 fallecieron (33 por ciento) y 8 permanecen vivos (66 por ciento).


We made a review of the clinical and pathological findings and the treatment in 12 patients presenting mucormycosis in the Clinical Hospital of the University of Chile between 1990 and 2004. Of the whole studied patients, 7 were men and 5 women. The average age was 54 years, with a range from 29 to 79 years. The diagnosis of mucormycosis was performed by biopsy in 10 patients andby direct study in 2 patients. The predisposing factors in the studied patients were: Diabetes Mellitus, HIV at AIDS stage and hematological diseases in oncologic treatment. The histology demonstrated necrosis and infarction with blood vessels invasion and mycotic thrombosis. All the studied patientsreceived treatment with Anphotericine B and 6 required surgical intervention. Of the total of 12 patients, 4 died (33 percent) and 8 remain alive (66 percent).


Subject(s)
Humans , Male , Adult , Female , Middle Aged , Mucormycosis/diagnosis , Mucormycosis/epidemiology , Mucormycosis/therapy , Zygomycosis/diagnosis , Zygomycosis/epidemiology , Zygomycosis/therapy , Comorbidity , Chile/epidemiology , /epidemiology , HIV Infections/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL